Publications for Lucia Ahlberg
Co-author map based on ISI articles 2007-

Publications mentioned in social media 26 times*

Keywords

trial treatment transplantation survival stem relapse randomized patients overall myeloma mg median iron epoetin dose disease consolidation bortezomib 90 30

Journal Articles

E. Hulegardh, H. Hagglund, Lucia Ahlberg, K. Karlsson, H. Karbach, A. Markuszewska, I. Persson, M. Astrom and H. Hallbook
  Outcome after HSCT in Philadelphia chromosome positive acute lymphoblastic leukemia in Sweden: a population-based study
  Medical Oncology, 2014, 31(8), 66.

Piotr Kozlowski, Maria Astrom, Lucia Ahlberg, Per Bernell, Erik Hulegardh, Hans Hagglund, Karin Karlsson, Alicja Markuszewska-Kuczymska, Beata Tomaszewska-Toporska, Bengt Smedmyr, Rose-Marie Amini and Helene Hallbook
  High relapse rate of T cell acute lymphoblastic leukemia in adults treated with Hyper-CVAD chemotherapy in Sweden
  European Journal of Haematology, 2014, 92(5), 377-381.

H W. Auner, R Szydlo, A van Biezen, S Iacobelli, G Gahrton, N Milpied, L Volin, J Janssen, S Nguyen Quoc, M Michallet, H Schoemans, J el Cheikh, E Petersen, F Guilhot, S Schoenland, Lucia Ahlberg, C Morris, L Garderet, T de Witte and N Kroeger
  Reduced intensity-conditioned allogeneic stem cell transplantation for multiple myeloma relapsing or progressing after autologous transplantation: a study by the European Group for Blood and Marrow Transplantation
 
Altmetric usage: 8

  Bone Marrow Transplantation, 2013, 48(11), 1395-1400.
 Web of Science® Times Cited: 2

Ulf-Henrik Mellqvist, Peter Gimsing, Oyvind Hjertner, Stig Lenhoff, Edward Laane, Kari Remes, Hlif Steingrimsdottir, Niels Abildgaard, Lucia Ahlberg, Cecilie Blimark, Inger Marie Dahl, Karin Forsberg, Tobias Gedde-Dahl, Henrik Gregersen, Astrid Gruber, Nina Guldbrandsen, Einar Haukas, Kristina Carlson, Ann Kristin Kvam, Hareth Nahi, Roald Lindas, Niels Frost Andersen, Ingemar Turesson, Anders Waage and Jan Westin
  Bortezomib consolidation after autologous stem cell transplantation in multiple myeloma: a Nordic Myeloma Study Group randomized phase 3 trial
 
Altmetric usage: 17

  Blood, 2013, 121(23), 4647-4654.
 Web of Science® Times Cited: 16

Piotr Kozlowski, Maria Astrom, Lucia Ahlberg, Per Bernell, Erik Hulegardh, Hans Hagglund, Karin Karlsson, Alicja Markuszewska-Kuczymska, Beata Tomaszewska-Toporska, Bengt Smedmyr and Helene Hallbook
  High curability via intensive reinduction chemotherapy and stem cell transplantation in young adults with relapsed acute lymphoblastic leukemia in Sweden 2003-2007
  Haematologica, 2012, 97(9), 1414-1421.
 Web of Science® Times Cited: 3

Peter Gimsing, Kristina Carlson, Ingemar Turesson, Peter Fayers, Anders Waage, Annette Vangsted, Anne Mylin, Christian Gluud, Gunnar Juliusson, Henrik Gregersen, Henrik Hjorth-Hansen, Ingerid Nesthus, Inger Marie S Dahl, Jan Westin, Johan Lanng Nielsen, Lene Meldgaard Knudsen, Lucia Ahlberg, Martin Hjorth, Niels Abildgaard, Niels Frost Andersen, Olle Linder and Finn Wisloeff
  Effect of pamidronate 30 mg versus 90 mg on physical function in patients with newly diagnosed multiple myeloma (Nordic Myeloma Study Group): a double-blind, randomised controlled trial
  LANCET ONCOLOGY, 2010, 11(10), 973-982.
 Web of Science® Times Cited: 27

Anders Waage, Peter Gimsing, Peter Fayers, Niels Abildgaard, Lucia Ahlberg, Bo Bjorkstrand, Kristina Carlson, Inger Marie Dahl, Karin Forsberg, Nina Gulbrandsen, Einar Haukas, Oyvind Hjertner, Martin Hjorth, Torbjorn Karlsson, Lene Meldgaard Knudsen, Johan Lanng Nielsen, Olle Linder, Ulf-Henrik Mellqvist, Ingerid Nesthus, Jurgen Rolke, Maria Strandberg, Finn Wisloff, Gunnar Juliusson and Ingemar Turesson
  Melphalan and prednisone plus thalidomide or placebo in elderly patients with multiple myeloma
 
Altmetric usage: 1

  BLOOD, 2010, 116(9), 1405-1412.
 Web of Science® Times Cited: 90

M Hedenus, G Birgegård, P Näsman, Lucia Ahlberg, T Karlsson, B Lauri, J Lundin, G Lärfars and A Österborg
  Addition of intravenous iron to epoetin beta increases hemoglobin response and decreases epoetin dose requirement in anemic patients with lymphoproliferative malignancies: A randomized multicenter study
  Leukemia, 2007, 21(4), 627-632.
 Web of Science® Times Cited: 99

Stig Lenhoff, Martin Hjorth, Ingemar Turesson, Jan Westin, Peter Gimsing, Finn Wisloff, Lucia Ahlberg, Kristina Carlson, Ilse Christiansen, Inger Marie Dahl, Karin Forsberg, Lorentz Brinch, Jens Hammerstrom, Hans E. Johnsen and Lene Me Knudsen
  Intensive therapy for multiple myeloma in patients younger than 60 years. Long-term results focusing on the effect of the degree of response on survival and relapse pattern after transplantation
  Haematologica, 2006, 91(9), 1228-1233.
 Web of Science® Times Cited: 33

C Crawley, M Lalancette, R Szydlo, M Gilleece, K Peggs, S Mackinnon, Gunnar Juliusson, Lucia Ahlberg, A Nagler, A Shimoni, A Sureda, JM Boiron, H Einsele, R Chopra, A Carella, J Cavenagh, A Gratwohl, F Garban, A Zander and B Bjorkstrand
  Outcomes for reduced-intensity allogeneic transplantation for multiple myeloma: an analysis of prognostic factors from the Chronic Leukaemia Working Party of the EBMT
  Blood, 2005, 105(11), 4532-4539.
 Web of Science® Times Cited: 141

Conference Articles

Meletios A Dimopoulos, Hadewijch M De Samblanx, Maria G Roussou, Konstantinos Zervas, Eirini Katodritou, Deniz Sargin, Cyrille Hulin, Lucia Ahlberg, Javier De La Rubia, Rita Ganguly, Joris K Diels, Helgi van de Velde, Ravinder Dhawan, Michael D Spencer and Michel Delforge
  Efficacy of Bortezomib Plus Dexamethasone Versus Bortezomib Mono therapy In Patients with Relapsed/Refractory Multiple Myeloma An Interim Report from an International Electronic Observational Study
  BLOOD vol 116, issue 21 (ISSN 0006-4971), 2010.


S Rosengren, Lucia Ahlberg, K Forsberg, S Lenhoff, U Mellqvist, H Nahi and K Carlson
  OUTCOME OF AUTOLOGOUS STEM CELL TRANSPLANTATION FOR AL-AMYLOIDOSIS IN SWEDEN in HAEMATOLOGICA-THE HEMATOLOGY JOURNAL, vol 95, issue , pp 393-393
  HAEMATOLOGICA-THE HEMATOLOGY JOURNAL, 2010.


Ulf-Henrik Mellqvist, Jan Westin, Oyvind Hjertner, Stig Lenhoff, Edward Laane, Kari Remes, Hlif Steingrimsdottir, Niels Abildgaard, Lucia Ahlberg, Kristina Carlsson, Karin Forsberg, Tobias Gedde-Dahl, Henrik Gregersen, Astrid Gruber, Nina Guldbrandsen, Einar Haukas, Olle Linder, Hareth Nahi, Ingerid Nesthus, Nilsaage Toffner-Clausen, Raija Silvennoinen, Niels Frost Andersen, Ingemar Turesson and Anders Waage
  Improved Response Rate with Bortezomib Consolidation After High Dose Melphalan: First Results of a Nordic Myeloma Study Group Randomized Phase III Trial in BLOOD, vol 114, issue 22, pp 221-221
  BLOOD, 2009.


 Web of Science® Times Cited: 5

K. Zervas, E. Katodritou, M. Delforge, H. de Samblanx, D. Sargin, C. Hulin, Lucia Ahlberg, J. de la Rubia, K. Abdulkadyrov, R. Ganguly, J. Diels and R. Dhawan
  PATIENT RESPONSE TO BORTEZOMIB IN RELAPSED/REFRACTORY MULTIPLE MYELOMA: INTERIM RESULTS FROM AN OBSERVATIONAL STUDY
  in HAEMATOLOGICA-THE HEMATOLOGY JOURNAL, vol 94, 2009.


M. Delforge, H. de Samblanx, K. Zervas, E. Katodritou, D. Sargin, C. Hulin, Lucia Ahlberg, J. de la Rubia, K. Abdulkadyrov, R. Ganguly, J. Diels and R. Dhawan
  SURVIVAL ANALYSIS OF PATIENTS WITH RELAPSED/REFRACTORY MULTIPLE MYELOMA: AN INTERIM REPORT FROM AN INTERNATIONAL ELECTRONIC OBSERVATIONAL STUDY OF BORTEZOMIB
  in HAEMATOLOGICA-THE HEMATOLOGY JOURNAL, vol 94, 2009.


* Social media data based on publications from 2011 to present and with a DOI; data delivered by Altmetric.com.